Display options
Cite
Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients. J Rheumatol. 2017;44(9):1417doi: 10.3899/jrheum.160871.C1.
(2017). Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients. The Journal of rheumatology, 44(9), 1417. https://doi.org/10.3899/jrheum.160871.C1
"Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients." The Journal of rheumatology vol. 44,9 (2017): 1417. doi: https://doi.org/10.3899/jrheum.160871.C1
Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients. J Rheumatol. 2017 Sep;44(9):1417. doi: 10.3899/jrheum.160871.C1. PMID: 28864670.
Copy Download .nbib Format: NLM
Share it on

J Rheumatol. 2017 Sep;44(9):1417. doi: 10.3899/jrheum.160871.C1.

Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.

The Journal of rheumatology

[No authors listed]

PMID: 28864670 DOI: 10.3899/jrheum.160871.C1

[No abstract available.]

Publication Types